Thiogenesis Therapeutics (TTI.V) Q3 2024 Earnings

30AugConfirmed
Q1 2024
Q3 2024
-0.01
0.32
0.66
0.99

Details

Expected EPS
N/A
Actual EPS
-0.00969777733
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Thiogenesis Therapeutics (TTI.V) has reported earnings of -0.00969777733 per share for Q3 2024.

0 Comments

Share your thoughts